Active infection swab test
Who can get tested: Active infection testing may be right for you if you are currently experiencing COVID-19 symptoms or were exposed to the virus in the last 14 days. Common COVID-19 symptoms include fever, cough, and shortness of breath.
How the test works: Your doctor or healthcare provider will collect a specimen through a nasal or throat swab. The specimen is then sent to Quest laboratories for processing using either our lab-developed test, a Roche-developed test, or a Hologic-developed test.
Where to get tested: Contact your doctor or healthcare provider for guidance on where in your community to get tested for an active infection. (Do not go to a Quest patient service center for this test.) You may also consider finding a testing location through national partnerships we have with Walmart, CVS Health or find local testing options through Google.
Active infection test fact sheets
- Quest-developed test
- Roche-developed test
- Hologic-developed Panther Fusion test
- Hologic-developed Panther test
- At-Home Self-Collection Kit instructions
Learn more about COVID-19 active infection testing.See FAQs
Getting test results through MyQuest
Confirm that the healthcare provider who collects your COVID-19 specimen is sending it to Quest for processing. If so, your test results can be sent to you automatically through the secure MyQuest™ online portal. This is usually the quickest way to get results.
Don’t have MyQuest?
Sign up now to get your COVID-19 test results online.
COVID-19 testing statements
- The antibody tests and the molecular tests (together “All tests”) have not been FDA cleared or approved;
- All tests have been authorized by FDA under EUAs for use by authorized laboratories;
- The antibody tests have been authorized only for the detection of IgG antibodies against SARS-CoV-2, not for any other viruses or pathogens;
- The molecular tests have been authorized only for the detection of nucleic acid from SARS-CoV-2, not for any other viruses, pathogens; and,
- All tests are only authorized for the duration of the declaration that circumstances exist justifying the authorization of emergency use of in vitro diagnostics for detection and/or diagnosis of COVID-19 under Section 564(b)(1) of the Act, 21 U.S.C. § 360bbb-3(b)(1), unless the authorization is terminated or revoked sooner.